CBT is the newest member of our growing family of minor cannabinoid products! Following the excitement of our exclusive CBG Oil, Extract Labs is proud to announce that we are producing CBT distillate! Extracted and processed in house from Colorado-grown hemp, CBT is featured in our CBD cartridges and available as pure distillate to our wholesale clients. So what is CBT?
What little is known about CBT is that it is found in highest concentrations in the distillates from the Type III flowers of the cannabis plant, which have high levels of cannabidiol (CBD) and low levels of tetrahydrocannabinol (THC). However, compared to most other cannabinoids, it is found in relatively low concentrations. Chemically, CBT is classified as a diether, which means that it has the same chemical relationship with CBD as CBD has with THC. Since it has the special quality of being the last cannabinoid retained on the chromatography column that chemists use to identify compounds, chemists may be able to use CBT as a marker for the end of all the known cannabinoids identified from a sample.
Even before it was discovered to be a naturally occurring cannabis product, CBT was synthesized in 1971 by the famed British natural chemist Leslie Crombie, who originally called it “cytrilidene cannabis”, suspecting that he had made a replica of a natural product from the cannabis plant. Two years later, that hunch proved true when Ludwig Bercht and colleagues isolated a product from cannabis resin and realized it was identical to the compound Crombie had created.
But after isolating CBT, precious few research studies have been published on its effects. One study, performed over 35 years ago by longtime cannabinoid researcher Mahmoud ElSohly, was promising: CBT was found to reduce pressure within the eyes in rabbits, making CBT a potential treatment for glaucoma and other conditions.
Like many minor cannabinoids, research has been limited due to cannabis prohibition. With the 2018 Farm bill removing hemp from Schedule 1 status and many states legalizing recreational marijuana, the doors will be open for the scientific community to be able to freely study many parts of the cannabis plant that are currently unknown. Much of the current attention is going towards CBD and THC as they are so abundant in cannabis, but as our knowledge of how these compounds interact with our body expands, focus will turn towards the other 120 minor cannabinoids we know very little about.
Extract Labs is on the cutting edge of extracting and processing minor cannabinoids. We are very excited to see what studies will reveal about the abilities of the cannabis plant to impact people’s lives, and to be able to supply consumers with clean, honest, and affordable products to allow everyone to see what they can do for them!
Cannabinoids in glaucoma II: The effect of different cannabinoids on intraocular pressure of the rabbit.